Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Opens Boston Area Proteomics Center

NEW YORK, June 26 - Ciphergen has opened a new proteomics center in the Boston area, the company said late Wednesday.


The center will provide services based on the company's SELDI-based ProteinChip technology and its BioSepra protein purification system, including large-scale protein expression, development of chromatography purification, development of analytical methods for proteomics, and furtherance of biomanufacturing processes.


Lisa Bradbury, a senior scientist at Ciphergen, will manage the center.


Ciphergen also has a proteomics center in Cergy-Saint-Christophe, near Paris.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.